Ernst Weber, Ph.D., is Head of Molecular Design & Engineering in the department of Antibody Lead Discovery and Optimization at Bayer AG. After receiving his Ph.D. in Biochemistry from the University of Halle (Germany), he conducted his Postdoc work as EMBO fellow at the MRC-LMB in Cambridge focusing on protein engineering. In 2008 he joined ICON Genetics where he developed new HTS compatible molecular biology technologies applicable to the optimization of single proteins but also complete enzymatic pathways. 2012 he moved to Bayer AG and is here responsible for antibody optimization and as project leader in Ophthalmology, Inflammation and Lung disease. Since 2015 he coordinates the setup of Bayer’s bispecific antibody platform.